163 related articles for article (PubMed ID: 7607727)
1. Chromogranin A in human hypertension. Influence of heredity.
Takiyyuddin MA; Parmer RJ; Kailasam MT; Cervenka JH; Kennedy B; Ziegler MG; Lin MC; Li J; Grim CE; Wright FA
Hypertension; 1995 Jul; 26(1):213-20. PubMed ID: 7607727
[TBL] [Abstract][Full Text] [Related]
2. Expression of altered alpha2-adrenergic phenotypic traits in normotensive humans at genetic risk of hereditary (essential) hypertension.
Dao TT; Kailasam MT; Parmer RJ; Le HV; Le Verge R; Kennedy BP; Ziegler G; Insel PA; Wright FA; O'Connor DT
J Hypertens; 1998 Jun; 16(6):779-92. PubMed ID: 9663918
[TBL] [Abstract][Full Text] [Related]
3. Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension.
O'Connor DT; Kailasam MT; Kennedy BP; Ziegler MG; Yanaihara N; Parmer RJ
J Hypertens; 2002 Jul; 20(7):1335-45. PubMed ID: 12131530
[TBL] [Abstract][Full Text] [Related]
4. Catecholamine storage vesicle protein expression in genetic hypertension.
O'Connor DT; Takiyyuddin MA; Printz MP; Dinh TQ; Barbosa JA; Rozansky DJ; Mahata SK; Wu H; Kennedy BP; Ziegler MG; Wright FA; Schlager G; Parmer RJ
Blood Press; 1999; 8(5-6):285-95. PubMed ID: 10803489
[TBL] [Abstract][Full Text] [Related]
5. Plasma chromogranin A. Initial studies in human hypertension.
O'Connor DT
Hypertension; 1985; 7(3 Pt 2):I76-9. PubMed ID: 3997234
[TBL] [Abstract][Full Text] [Related]
6. Circulating amylin in human essential hypertension: heritability and early increase in individuals at genetic risk.
Kailasam MT; Parmer RJ; Tyrell EA; Henry RR; O'Connor DT
J Hypertens; 2000 Nov; 18(11):1611-20. PubMed ID: 11081774
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunoassay of chromogranin A in plasma as a measure of exocytotic sympathoadrenal activity in normal subjects and patients with pheochromocytoma.
O'Connor DT; Bernstein KN
N Engl J Med; 1984 Sep; 311(12):764-70. PubMed ID: 6472366
[TBL] [Abstract][Full Text] [Related]
8. Chromogranin A: implications for hypertension.
O'Connor DT
J Hypertens Suppl; 1984 Dec; 2(3):S147-50. PubMed ID: 6599663
[TBL] [Abstract][Full Text] [Related]
9. Chromogranin A immunoreactivity in human cerebrospinal fluid: properties, relationship to noradrenergic neuronal activity, and variation in neurologic disease.
O'Connor DT; Cervenka JH; Stone RA; Parmer RJ; Franco-Bourland RE; Madrazo I; Langlais PJ
Neuroscience; 1993 Oct; 56(4):999-1007. PubMed ID: 7904334
[TBL] [Abstract][Full Text] [Related]
10. Chromogranin 'A' in normal subjects, essential hypertensives and adrenalectomized patients.
Giampaolo B; Angelica M; Antonio S
Clin Endocrinol (Oxf); 2002 Jul; 57(1):41-50. PubMed ID: 12100068
[TBL] [Abstract][Full Text] [Related]
11. The catecholamine release-inhibitory "catestatin" region of chromogranin a: early decline in humans at genetic risk of hypertension.
O'Connor DT; Kailasam MT; Kennedy BP; Ziegler MG; Yanaihara N; Parmer RJ
Ann N Y Acad Sci; 2002 Oct; 971():533-5. PubMed ID: 12438176
[No Abstract] [Full Text] [Related]
12. Spontaneously hypertensive rat Y chromosome increases indexes of sympathetic nervous system activity.
Ely D; Caplea A; Dunphy G; Daneshvar H; Turner M; Milsted A; Takiyyudin M
Hypertension; 1997 Feb; 29(2):613-8. PubMed ID: 9040447
[TBL] [Abstract][Full Text] [Related]
13. Is physiologic sympathoadrenal catecholamine release exocytotic in humans?
Takiyyuddin MA; Cervenka JH; Sullivan PA; Pandian MR; Parmer RJ; Barbosa JA; O'Connor DT
Circulation; 1990 Jan; 81(1):185-95. PubMed ID: 2404624
[TBL] [Abstract][Full Text] [Related]
14. Chromogranin A storage and secretion: sensitivity and specificity for the diagnosis of pheochromocytoma.
Hsiao RJ; Parmer RJ; Takiyyuddin MA; O'Connor DT
Medicine (Baltimore); 1991 Jan; 70(1):33-45. PubMed ID: 1988765
[TBL] [Abstract][Full Text] [Related]
15. Catecholamine storage vesicles: role of core protein genetic polymorphisms in hypertension.
Zhang K; Chen Y; Wen G; Mahata M; Rao F; Fung MM; Vaingankar S; Biswas N; Gayen JR; Friese RS; Mahata SK; Hamilton BA; O'Connor DT
Curr Hypertens Rep; 2011 Feb; 13(1):36-45. PubMed ID: 21104344
[TBL] [Abstract][Full Text] [Related]
16. Plasma chromogranin A as a marker of sympathochromaffin activity in humans.
Cryer PE; Wortsman J; Shah SD; Nowak RM; Deftos LJ
Am J Physiol; 1991 Feb; 260(2 Pt 1):E243-6. PubMed ID: 1996627
[TBL] [Abstract][Full Text] [Related]
17. Catecholamine secretory vesicles. Augmented chromogranins and amines in secondary hypertension.
Takiyyuddin MA; De Nicola L; Gabbai FB; Dinh TQ; Kennedy B; Ziegler MG; Sabban EL; Parmer RJ; O'Connor DT
Hypertension; 1993 May; 21(5):674-9. PubMed ID: 8491501
[TBL] [Abstract][Full Text] [Related]
18. Suppression of chromogranin-A release from neuroendocrine sources in man: pharmacological studies.
Takiyyuddin MA; Baron AD; Cervenka JH; Barbosa JA; Neumann HP; Parmer RJ; Sullivan PA; O'Connor DT
J Clin Endocrinol Metab; 1991 Mar; 72(3):616-22. PubMed ID: 1671783
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation within a metabolic motif in the chromogranin a promoter: pleiotropic influence on cardiometabolic risk traits in twins.
Rao F; Chiron S; Wei Z; Fung MM; Chen Y; Wen G; Khandrika S; Ziegler MG; Benyamin B; Montgomery G; Whitfield JB; Martin NG; Waalen J; Hamilton BA; Mahata SK; O'Connor DT
Am J Hypertens; 2012 Jan; 25(1):29-40. PubMed ID: 21918574
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine sources of chromogranin-A in normal man: clues from selective stimulation of endocrine glands.
Takiyyuddin MA; Cervenka JH; Pandian MR; Stuenkel CA; Neumann HP; O'Connor DT
J Clin Endocrinol Metab; 1990 Aug; 71(2):360-9. PubMed ID: 2116438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
